3ET7: Crystal Structure Of Pyk2 Complexed With Pf-2318841
reference: Trifluoromethylpyrimidine-based inhibitors of proline-rich tyrosine kinase 2 (PYK2): structure-activity relationships and strategies for the elimination of reactive metabolite formation., Walker DP, Bi FC, Kalgutkar AS, Bauman JN, Zhao SX, Soglia JR, Aspnes GE, Kung DW, Klug-McLeod J, Zawistoski MP, McGlynn MA, Oliver R, Dunn M, Li JC, Richter DT, Cooper BA, Kath JC, Hulford CA, Autry CL, Luzzio MJ, Ung EJ, Roberts WG, Bonnette PC, Buckbinder L, Mistry A, Griffor MC, Han S, Guzman-Perez A, Bioorg Med Chem Lett. 2008 Dec 1;18(23):6071-7. Epub 2008 Oct 11. PMID: 18951788

This OCA Structure page
uses Jmol, developed by the Jmol Development Team (documentation).